New shot aims to ease dangerous pregnancy condition
NCT ID NCT07282171
First seen Jan 08, 2026 · Last updated May 15, 2026 · Updated 18 times
Summary
This early-stage study tests a single injection of CBP-4888 in 60 pregnant women hospitalized with preterm preeclampsia, a serious condition involving high blood pressure and organ stress. The goal is to find a safe dose and see how the drug affects the body. Participants receive standard care plus the study drug, and both mothers and babies are monitored for several months after delivery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Royal Melbourne
RECRUITINGMelbourne, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Royal Women's Hospital
RECRUITINGParkville, Victoria, 3052, Australia
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.